TUBERCULOUS MENINGITIS, as is well known, is a subacute infection of the central nervous system. Much of the literature on this disease has recently been reviewed by Schwarz (1948). The main pathological differences between untreated cases and those treated with streptomycin, yet coming to necropsy, are due as far as one can see to a prolongation, a slowing down or even a regression and healing of the disease process.
Proceedings of the Royal Society of Medticine 22 cerebral arteries. Running anteriorly is the cistern of the lamina terminalis containing the anterior cerebral arteries. Postero-superiorly run the cisterna ambiens, embracing the mi.dbrain and ending in a moderate sized expansion beneath the splenium of the corpus callosum, adjacent to the pineal body and the great vein of Galen. The cisterna ambiens contains the origins of the posterior cerebral and superior cerebellar arteries and the optic tracts lie along their medial walls. It will thus be seen that the origins of all the major cerebral arteries lie in extensions of the main subarachnoid lake at the base of the brain, and that when this lake and its extensions become filled with exudate these vessels and, what is more important, their small branches, must be bathed by the exudate. In cases in which life has been considerably prolonged by streptomycin treatment this basal exudate is usually thicker than it is in untreated fatal cases and instead of being gelatinous is of a wooden-hard consistency ( fig. 1) .
We know that arteries embedded in tuberculous exudate commonly develop an arteritis (Hektoen, 1896; Askanazy, 1910; Winkelman and Moore, 1940; Smith and Daniel, 1947) with consequent diminution or even obliteration of their lumina, and this arteritis of the proximal parts of the main cerebral arteries and their branches is one of the most serious and fatal concomitants of the basal exudate. The result of the arteritis is at the best some degree of anoxia, and at the worst actual infarction of the territory supplied by the affected vessel (Smith and Daniel, 1947; Smith, Vollum and Cairns, 1948) .
The morbid anatomical changes in some streptomycin-treated cases of tuberculous meningitis are shown. Fig. 2 shows the collar of exudate around the mid-brain, which impedes or stops the circulation of cerebrospinal fluid up through the tentorial opening and gives rise to communicating hydrocephalus. Involvement of the small vessels supplying the mid-brain which lie in the collar of exudate may lead to infarction of any part of it, and produce mid-brain lesions and signs. Fig. 3 illustrates a case of this type in which there is shrinkage of the whole of a frontal FIG. 3.-Inferior aspect of the frontal lobes of a case of tuberculous meningitis which had been treated with streptomycin. She survived for over six months. The left frontal lobe is much reduced in size and a deep well-defined depression is seen lateral to the olfactory bulb. This is a very characteristic finding in cases which have infarction of the basal ganglia of long standing. The infarction is due to tuberculous arteritis.
lobe as a result of infarction of the basal ganglia, due to arteritis of the branches of the cerebral arteries supplying them (Abbie, 1937; Alexander, 1942) . Fig. 4 shows the same brain in coronal section. The The tremendous importance of early diagnosis and treatment lies in the need to prevent or diminish the formation of basal exudate. If this can be prevented from developing to any serious extent, then the irreversible changes due to arterial involvement, such as infarction of the basal ganglia ( fig. 6 ), internal capsule, hypothalamus, optic chiasm and tracts, and brain-stem ( fig. 7) , and the development of severe hydrocephalus, may be avoided. This paper is to be published in the Journal ofPathology and Bacteriology Dr. I. A. B. Cathie: Clinical Pathology.-It is very rare for the tubercle bacillus on primary isolation from the cerebrospinal fluid to have a greater resistance to streptomycin than 1 unit per ml., and the majority of strains are inhibited by i unit or less. With the methods at present available the estimation of sensitivity may take up to three months, and treatment is often nearly finished by this time. During this period assumption of streptomycin sensitivity may confidently be made,, but with the increasing number of strains of resistant bacilli which are emerging from treated cases of tuberculosis early knowledge of sensitivity is likely to become of more importance during the next few years.
When streptomycin is given intramuscularly in amounts of O002 gramme per lb. of bodyweight per day, either six-hourly or twelve-hourly, reasonably consistent blood levels are obtained, ranging from 32-64 units per ml. after one hour to 2-4 units after twelve hours.
Where there is no meningitis streptomycin from the blood-stream penetrates with difficulty into the C.S.F., and levels usually less than 1 unit are found. But where there is meningeal inflammation, intramuscular streptomycin-passes the blood-brain barrier more readily, and levels of around 4 units are present. This observation has proved valuable in distinguishing tuberculous meningitis from encephalitis, poliomyelitis and similar conditions.
Streptomycin intrathecally in doses of 0 I gramme over the age of 3, and half this amount understand that the relative avascularity of such lesions will not permit the penetration of streptomycin, and so the likelihood of reinfection exists. But once the organism has been discharged into the C.S.F. it cannot multiply unless or until it settles on some damaged area, and in the C.S.F. it ought to be readily dealt with by the concentration of streptomycin which can be obtained.
What is being called tuberculous meningismus has been seen three times in treating 20 cases of miliary tuberculosis. Routine lumbar puncture has shown a sudden rise in cells and protein with a normal sugar content. Tubercle bacilli were not seen or grown, and the C.S.F. returned to normal within a week. As none of the three patients showing these changes died there has been no opportunity of ascertaining the type of lesion causing them, and we can only speculate on the possibilities of rupturing tuberculomata and new waves of hematogenous spread.
Some cases of tuberculous meningitis seem to hold their own for two or three months and then go downhill rapidly, suggesting that an opportunity has been lost of curing the disease while it has not been actively progressing. This observation has led to the trial of other drugs in combination with streptomycin during this period. The classical gelatinous exudate at the base of the brain is, in the earlier stages at least, fibrinous, and can be shown to contain tubercle bacilli to which streptomycin presumably cannot penetrate. It has seemed reasonable to attack this fibrinous exudate by all means available, and latterly we have been using a fibrinolysin prepared from heemolytic streptococci. This, after purification, can be given intrathecally without causing much responise, and it may be mixed with streptomycin. The first child to whom it was given had been abandoned as a failure and had been off all treatment for six weeks. Tubercle bacilli had not been seen in the C.S.F. for five months, yet after three days' intrathecal fibrinolysin they reappeared. This was regarded as a promising result, suggesting that the bacteria had been released from the exudate to become accessible to streptomycin. The second child had had a sterilized influenzal meningitis but was left with a basal block. After seventeen days of fibrinolysin by lumbar puncture unblocking occurred, with an equalizing of cells and protein between the lumbar and ventricular C.S.F.
Encouraged by these results we have used fibrinolysin in combination with streptomycin in all subsequent cases of tuberculous meningitis, and although it is too soon to know anything of the remote results the immediate response certainly seems to be better.
However the future of streptomycin treatment develops it seems likely that some form of enabling agent will have to be given to facilitate the penetration of streptomycin to bacteria in sites usually inaccessible, and for this purpose bacterial fibrinolysin appears to be worthy of further investigation.
Sir Hugh Cairns, in reply, said that it was inevitable at this stage of our experience that any discussion on the results of treatment of tuberculous meningitis should be somewhat indeterminate. In another year we should know much more provided cases were sent to centres where there was a consistent policy as to treatment and careful record of results. The addition of fibrinolysins, and such substances as para-amino-salicylic acid and promizole, was all to the good provided these substances were applied in a planned and systematic manner. In reply to the President's question as to what had happened to the basal exudate of the patient shown at the meeting, Professor Cairns imagined that during the twenty months in which the patient's C.S.F. had remained abnormal this exudate was undergoing gradual resolution, but that it had all disappeared when the C.S.F. became normal. As to the ultimate fate of the patient, time alone would show whether he would maintain his present excellent, state of health. A. E. Martin's study of the literature on spontaneous recovery from tuberculous meningitis had shown that there was a late relapse of tuberculosis in some form in a certain number of cases, and so late relapse must be regarded as a possibility in all the apparent cures by streptomycin.
Dr. Purdon Martin had pointed out that the outcome in any one case must depend to a considerable extent upon the resisting powers of the patient. Professor Cairns agreed with this view, but he knew no way of measuring the resistance other than by estimating the character and extent of the tuberculous lesions in other parts of the body, as shown in Table III . In view of the varying resistance and of our inability to measure it accurately it was surely important in tuberculous meningitis, as in tuberculosis of other parts of the body, to treat patients most carefully after recovery from the symptoms of meningitis.
No matter how quick the clinical recovery, the exudate evidently took a long time to absorb. Because they seemed well patients should not be discharged to their homes after conclusion of a course of treatment, but should be given careful sanatorium treatment with good feeding and graduated exercise.
One speaker had stated that the Oxford results were twice as good as those of any other clinic, but Professor Cairns doubted whether this was correct. Dr. J. Rubie at Highgate had reported that of his first 54 cases 14 had become symptom-free with a normal C.S.F. This was one way in which the results of different centres might be compared: from all the patients who have completed treatment how many remain who are symptom-free and have normal C.S.F.? As far as the Oxford results were concerned there were three points to emphasize: (1) They were the result of prolonged continuous treatment with streptomycin followed by sanatorium treatment. (2) Special care was exercised in the intrathecal treatment: in each case, particularly in infants, the lumbar punctures were done by one person only. (3) The results were those of one centre: in the nature of things it was probable that a series collected from multiple centres would always show worse results than a series from a single centre.
Professor Cairns agreed with Dr. J. Rubie that the C.S.F. tended to return to normal more quickly in children than in adults, who after clinical recovery consistently showed a long period in which white cells ranged from 10 to 20 per c.mm. and protein from 40 to 80 mg.%. In the treatment of raised intracranial pressure, at Oxford they preferred intermittent ventricular puncture to drainage of the ventricle by indwelling catheter. The latter method carried the risks of infection with streptomycin-resistant organisms, and of cerebrospinal fistula; also, in the early stages of the disease, drainage of the ventricular fluid was followed by great rise of the protein content of the lumbar and cisternal C.S.F. even up to 400 of protein, with consequent increased risk of acute hydrocephalus from complete fibrinous blockage of the cisterns at the tentorial opening.
In reply to Dr. Colin Edwards' question as to when streptomycin treatment should Pe stopped, this was sometimes an extremely difficult question to decide. Intrathecal treatment was given for not less than 42 consecutive days and usually for 60 days; if during the second month of that treatment there was any evidence of active disease, such as a positive film or culture from the C.S.F., or a clinical episode such as a cranial nerve palsy or hemiplegia, intrathecal treatment was continued for a further 42 days from that time.
Intramuscular streptomycin was given for 180 consecutive days, and was continued longer if there was late evidence of active disease, or if at the end of the 180 days the white cell count of the C.S.F. was not below 50 per c.mm. and falling. They had not found towards the end of a six months' course of treatment that the cell count and protein were being maintained at a high level as a result of the continued use of streptomycin. At this stage of the disease the cell and protein content of the C.S.F. were of great importance and could be regarded as an indication of the stage which resolution of the disease had reached. But the question of when to stop treatment was often difficult to decide.
Dr. Margaret Taylor, in reply to a question, stated that 20 of their patients at Oxford had been aged 7 years or less. Of these 9 had died, 7 had completed treatment and were symptom-free, and 4 were still undergoing treatment mostly in the fourth month of their course. The results for the children of 7 and under were thus approximately the same as those for the whole group.
